Heparin interference in the cerebrospinal fluid protein assay measured with a pyrogallol red-molybdate complex

Clinica Chimica Acta

Volumn 408, Issue 1-2, 2009, Pages 75-78

  Yang, Jui Yi ^a   Chien, Tzu I ^a   Lu, Jin Ying ^a   Kao, Jau Tsuen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

CSF protein; Heparin; Interference; Pyrogallol red molybdate complex

Indexed keywords

HEPARIN; MOLYBDIC ACID; PROTAMINE; PYROGALLOL; SODIUM CHLORIDE;

ANALYTICAL EQUIPMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DILUTION; EXPERIMENTAL DESIGN; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION;

ARTIFACTS; CEREBROSPINAL FLUID PROTEINS; CLINICAL CHEMISTRY TESTS; HEPARIN; HUMANS; MOLYBDENUM; ORGANOMETALLIC COMPOUNDS; PROTAMINES; PYROGALLOL;

EID: 69849087530     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.07.011     Document Type: Article

References (16)

1. Chakrabarti A.K. Significance of raised protein content in cerebrospinal fluid (a review). Neurol India 23 (1975) 23-31
2. Ihekwaba U.K., Kudesia G., and McKendrick M.W. Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. Clin Infect Dis 47 (2008) 783-789
3. Ray P., Badarou-Acossi G., Viallon A., et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med 25 (2007) 179-184
4. Gerbaut L., and Macart M. Is standardization more important than methodology for assay of total protein in cerebrospinal fluid?. Clin Chem 32 (1986) 353-355
5. Lott J.A., and Warren P. Estimation of reference intervals for total protein in cerebrospinal fluid. Clin Chem 35 (1989) 1766-1770
6. Marshall T., and Williams K.M. Interference in the Coomassie Brilliant Blue and Pyrogallol Red protein dye-binding assays is increased by the addition of sodium dodecyl sulfate to the dye reagents. Anal Biochem 331 (2004) 255-259
7. Yilmaz F.M., and Yucel D. Effect of addition of hemolysate on urine and cerebrospinal fluid assays for protein. Clin Chem 52 (2006) 152-153
8. Watanabe N., Kamei S., Ohkubo A., et al. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 32 (1986) 1551-1554
9. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
10. Speth M., Seibold K., and Katz N. Interaction between heparin and cardiac troponin T and troponin I from patients after coronary bypass surgery. Clin Biochem 35 (2002) 355-362
11. Stiegler H., Fischer Y., Vazquez-Jimenez J.F., et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 46 (2000) 1338-1344
12. Wannasilp N., Sribhen K., Pussara N., Hwanpuch T., Wangchaijaroenkit S., and Opartkiattikul N. Heparin is an unsuitable anticoagulant for the detection of plasma ammonia. Clin Chim Acta 371 (2006) 196-197
13. Wannasilp N., Sribhen K., Pussara N., and Opartkiatikul N. EDTA should be the anticoagulant of choice for the measurement of plasma ammonia: report of a problem sample. Clin Chim Acta 357 (2005) 84-85
14. Nongynecologic cytology practice guideline. Acta Cytol 2004; 48:521-546.
15. Biou D., Benoist J.F., Nguyen-Thi C., Huong X., Morel P., and Marchand M. Cerebrospinal fluid protein concentrations in children: age-related values in patients without disorders of the central nervous system. Clin Chem 46 (2000) 399-403
16. Griffin M.J., Rinder H.M., Smith B.R., et al. The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress. Anesth Analg 93 (2001) 20-27